Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Kramer

Showing results (161-170 of 165) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 165 results.
Thrombosis Research|March 9, 2000
Epitope mapping of monoclonal antibodies directed to PAI-1 using PAI-1/PAI-2 chimera and PAI-1-derived synthetic peptidesB Muehlenweg, E Guthaus, N A de Prada, et al.
International Journal of Oncology|September 21, 2000
New ELISA for quantitation of human urokinase receptor (CD87) in cancerM Kotzsch, T Luther, N Harbeck, et al.
The New England Journal of Medicine|December 3, 1998
Therapy with a purified plasminogen concentrate in an infant with ligneous conjunctivitis and homozygous plasminogen deficiencyD Schott, C E Dempfle, P Beck, et al.
Cancer Research|February 17, 2000
The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patientsJ A Foekens, H A Peters, M P Look, et al.
British Journal of Cancer|December 4, 1998
External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in human breast cancer tissue extractsC G Sweep, J Geurts-Moespot, N Grebenschikov, et al.
Pageof 17

Showing results (161-170 of 165) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 165 results.
Thrombosis Research|March 9, 2000
Epitope mapping of monoclonal antibodies directed to PAI-1 using PAI-1/PAI-2 chimera and PAI-1-derived synthetic peptidesB Muehlenweg, E Guthaus, N A de Prada, et al.
International Journal of Oncology|September 21, 2000
New ELISA for quantitation of human urokinase receptor (CD87) in cancerM Kotzsch, T Luther, N Harbeck, et al.
The New England Journal of Medicine|December 3, 1998
Therapy with a purified plasminogen concentrate in an infant with ligneous conjunctivitis and homozygous plasminogen deficiencyD Schott, C E Dempfle, P Beck, et al.
Cancer Research|February 17, 2000
The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patientsJ A Foekens, H A Peters, M P Look, et al.
British Journal of Cancer|December 4, 1998
External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in human breast cancer tissue extractsC G Sweep, J Geurts-Moespot, N Grebenschikov, et al.
Pageof 17